PyInvesting

Market research

IART Integra LifeSciences Holdings

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
1B
P/E ratio
Not available
Analyst target
19.5556
Dividend yield
Not available
Beta
1.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Integra LifeSciences Holdings Corporation is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.

From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.

Integra LifeSciences Holdings Corporation's total revenue sank by 1.6% to $389M since the same quarter in the previous year.

Its net income has increased by 505.4% to $93M since the same quarter in the previous year.

Finally, its free cash flow fell by 22.6% to $52M since the same quarter in the previous year.

Based on the above factors, Integra LifeSciences Holdings Corporation gets an overall score of 3/5.